Pro Share Advisors LLC Eye Point Pharmaceuticals, Inc. Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 15,282 shares of EYPT stock, worth $181,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,282
Previous 17,229
11.3%
Holding current value
$181,702
Previous $93,000
53.76%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
160Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$99 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$80.9 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$80.9 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$54.7 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$51.1 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $405M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...